Evidence map›Paper›PMID 36712803›Full record

ArticlePNAS nexus2022

Can vaccine prioritization reduce disparities in COVID-19 burden for historically marginalized populations?

Erik T Rosenstrom, Jessica Mele, Julie S Ivy, Maria E Mayorga, Mehul D Patel, Kristen Hassmiller Lich, Karl Johnson, Paul Delamater, Pinar Keskinocak, Ross Boyce and 2 more

Abstract read
In one paragraph

Article in PNAS nexus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Erik T RosenstromDepartment of Industrial and Systems Engineering, North Carolina State University, 915 Partners Way, Campus Box 7906, Raleigh, NC 27606, USA.
Jessica MeleDepartment of Industrial and Systems Engineering, North Carolina State University, 915 Partners Way, Campus Box 7906, Raleigh, NC 27606, USA.
Julie S IvyDepartment of Industrial and Systems Engineering, North Carolina State University, 915 Partners Way, Campus Box 7906, Raleigh, NC 27606, USA.
Maria E MayorgaDepartment of Industrial and Systems Engineering, North Carolina State University, 915 Partners Way, Campus Box 7906, Raleigh, NC 27606, USA.
Mehul D PatelDepartment of Emergency Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Kristen Hassmiller LichDepartment of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Karl JohnsonDepartment of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Paul DelamaterDepartment of Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID https://orcid.org/0000-0003-3627-9739
Pinar KeskinocakDepartment of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.ORCID https://orcid.org/0000-0003-2686-546X
Ross BoyceDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID https://orcid.org/0000-0002-9489-6324
Raymond SmithDepartment of Engineering, East Carolina University, Greenville, NC 27834, USA.
Julie L SwannDepartment of Industrial and Systems Engineering, North Carolina State University, 915 Partners Way, Campus Box 7906, Raleigh, NC 27606, USA.

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Understanding the relationship between herd immunity and geographic scale to improve estimates of localized infectious disease outbreak riskK01AI151197 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DELAMATER, PAUL · 2020 to 2023
$544k
NCATS NIH HHS UL1 TR002489NIAID NIH HHS K01 AI151197NICHD NIH HHS P2C HD050924
6 · The paper itself

Abstract

SARS-CoV-2 vaccination strategies were designed to reduce COVID-19 mortality, morbidity, and health inequities. To assess the impact of vaccination strategies on disparities in COVID-19 burden among historically marginalized populations (HMPs), e.g. Black race and Hispanic ethnicity, we used an agent-based simulation model, populated with census-tract data from North Carolina. We projected COVID-19 deaths, hospitalizations, and cases from 2020 July 1 to 2021 December 31, and estimated racial/ethnic disparities in COVID-19 outcomes. We modeled 2-stage vaccination prioritization scenarios applied to sub-groups including essential workers, older adults (65+), adults with high-risk health conditions, HMPs, or people in low-income tracts. Additionally, we estimated the effects of maximal uptake (100% for HMP vs. 100% for everyone), and distribution to only susceptible people. We found strategies prioritizing essential workers, then older adults led to the largest mortality and case reductions compared to no prioritization. Under baseline uptake scenarios, the age-adjusted mortality for HMPs was higher (e.g. 33.3%-34.1% higher for the Black population and 13.3%-17.0% for the Hispanic population) compared to the White population. The burden on HMPs decreased only when uptake was increased to 100% in HMPs; however, the Black population still had the highest relative mortality rate even when targeted distribution strategies were employed. If prioritization schemes were not paired with increased uptake in HMPs, disparities did not improve. The vaccination strategies publicly outlined were insufficient, exacerbating disparities between racial and ethnic groups. Strategies targeted to increase vaccine uptake among HMPs are needed to ensure equitable distribution and minimize disparities in outcomes.

Indexed as

agent base simulationCOVID-19health disparitiesvaccine equity

Identifiers

PMID36712803
PMCPMC9801966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.